Valeant Pharmaceuticals International Inc (NYSE:VRX)

237.53
Delayed Data
As of May 22
 +4.26 / +1.83%
Today’s Change
106.00
Today|||52-Week Range
238.49
+65.98%
Year-to-Date

Today’s Trading

Previous close233.27
Today’s open233.17
Day’s range232.03 - 238.49
Volume1,945,397
Average volume (3 months)2,866,064
Market cap$81.0B
Dividend yield--
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+32.91%
Earnings growth (next 5 years)+26.30%
Revenue growth (last year)+43.22%
P/E ratio88.8
Price/Sales5.83
Price/Book14.95

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.03+0.04%
AZNAstraZeneca-0.41-0.59%
ABTAbbott Laboratories-0.31-0.63%
CELGCelgene-0.11-0.09%
Data as of 4:01pm ET, 05/22/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)$2.44
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers